TMS for Complex Regional Pain Syndrome
Launched by STANFORD UNIVERSITY · Apr 28, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a treatment called Transcranial Magnetic Stimulation (TMS) for people suffering from Complex Regional Pain Syndrome (CRPS), a condition that causes severe pain and other symptoms in a specific area of the body. The study aims to see if TMS can help reduce pain and improve overall well-being compared to a sham (placebo) treatment. Participants will receive TMS once daily for two days and will be monitored for two weeks to see if they feel better and how long the relief lasts.
To be eligible for this study, participants must be between 18 and 70 years old and have been diagnosed with CRPS for at least three months. They should also have a certain level of pain that meets the study's criteria. However, individuals with certain medical conditions, like those with metal implants, a history of epilepsy, or pregnancy, cannot participate. If you join the trial, you can expect to undergo TMS treatment and follow-up assessments to track your pain and symptoms. This study is currently recruiting participants of all genders, so if you or someone you know is interested, it could be a chance to explore a new treatment option.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-70
- • Diagnosis of CRPS (complex regional pain syndrome) for at least 3 months
- • Average pain level reported on Numerical Rating Scale meets entry criteria
- • Ability to perform the experimental task and procedures.
- Exclusion Criteria:
- • MRI contraindication (metal implants or devices, claustrophobia)
- • TMS Contraindication (eg metal implant or devices near the site of stimulation)
- • History of epilepsy
- • History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
- • Neurologic illness that would interfere with brain integrity
- • Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
- • Currently pregnant or planning to become pregnant.
- • On going legal action or disability claim.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Redwood City, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials